Switch to:
Also traded in: Germany

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 5/10

vs
industry
vs
history
Cash-to-Debt 0.06
EVHC's Cash-to-Debt is ranked lower than
81% of the 257 Companies
in the Global Medical Care industry.

( Industry Median: 0.40 vs. EVHC: 0.06 )
Ranked among companies with meaningful Cash-to-Debt only.
EVHC' s Cash-to-Debt Range Over the Past 10 Years
Min: 0.04  Med: 0.12 Max: 0.71
Current: 0.06
0.04
0.71
Equity-to-Asset 0.40
EVHC's Equity-to-Asset is ranked lower than
62% of the 253 Companies
in the Global Medical Care industry.

( Industry Median: 0.47 vs. EVHC: 0.40 )
Ranked among companies with meaningful Equity-to-Asset only.
EVHC' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.31  Med: 0.5 Max: 0.77
Current: 0.4
0.31
0.77
Interest Coverage 4.72
EVHC's Interest Coverage is ranked lower than
66% of the 216 Companies
in the Global Medical Care industry.

( Industry Median: 8.17 vs. EVHC: 4.72 )
Ranked among companies with meaningful Interest Coverage only.
EVHC' s Interest Coverage Range Over the Past 10 Years
Min: 2.64  Med: 15.85 Max: 29.05
Current: 4.72
2.64
29.05
Piotroski F-Score: 5
Altman Z-Score: 0.86
Beneish M-Score: 0.25
WACC vs ROIC
3.82%
4.66%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 8/10

vs
industry
vs
history
Operating Margin % 10.18
EVHC's Operating Margin % is ranked higher than
58% of the 255 Companies
in the Global Medical Care industry.

( Industry Median: 7.71 vs. EVHC: 10.18 )
Ranked among companies with meaningful Operating Margin % only.
EVHC' s Operating Margin % Range Over the Past 10 Years
Min: 10.18  Med: 31.19 Max: 35.09
Current: 10.18
10.18
35.09
Net Margin % -0.50
EVHC's Net Margin % is ranked lower than
77% of the 256 Companies
in the Global Medical Care industry.

( Industry Median: 4.84 vs. EVHC: -0.50 )
Ranked among companies with meaningful Net Margin % only.
EVHC' s Net Margin % Range Over the Past 10 Years
Min: -0.5  Med: 6.92 Max: 8.52
Current: -0.5
-0.5
8.52
ROE % -0.86
EVHC's ROE % is ranked lower than
82% of the 240 Companies
in the Global Medical Care industry.

( Industry Median: 9.89 vs. EVHC: -0.86 )
Ranked among companies with meaningful ROE % only.
EVHC' s ROE % Range Over the Past 10 Years
Min: -0.61  Med: 9.45 Max: 11.71
Current: -0.86
-0.61
11.71
ROA % -0.21
EVHC's ROA % is ranked lower than
76% of the 259 Companies
in the Global Medical Care industry.

( Industry Median: 4.66 vs. EVHC: -0.21 )
Ranked among companies with meaningful ROA % only.
EVHC' s ROA % Range Over the Past 10 Years
Min: -0.16  Med: 3.56 Max: 6.44
Current: -0.21
-0.16
6.44
ROC (Joel Greenblatt) % 65.63
EVHC's ROC (Joel Greenblatt) % is ranked higher than
80% of the 257 Companies
in the Global Medical Care industry.

( Industry Median: 21.13 vs. EVHC: 65.63 )
Ranked among companies with meaningful ROC (Joel Greenblatt) % only.
EVHC' s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: 41.35  Med: 124.8 Max: 236.73
Current: 65.63
41.35
236.73
3-Year Revenue Growth Rate 23.70
EVHC's 3-Year Revenue Growth Rate is ranked higher than
90% of the 183 Companies
in the Global Medical Care industry.

( Industry Median: 8.50 vs. EVHC: 23.70 )
Ranked among companies with meaningful 3-Year Revenue Growth Rate only.
EVHC' s 3-Year Revenue Growth Rate Range Over the Past 10 Years
Min: 9.6  Med: 15.4 Max: 23.7
Current: 23.7
9.6
23.7
3-Year EBITDA Growth Rate -7.90
EVHC's 3-Year EBITDA Growth Rate is ranked lower than
79% of the 161 Companies
in the Global Medical Care industry.

( Industry Median: 8.10 vs. EVHC: -7.90 )
Ranked among companies with meaningful 3-Year EBITDA Growth Rate only.
EVHC' s 3-Year EBITDA Growth Rate Range Over the Past 10 Years
Min: -9  Med: 12.3 Max: 40.5
Current: -7.9
-9
40.5
GuruFocus has detected 5 Warning Signs with Envision Healthcare Corp $EVHC.
More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.
» EVHC's 10-Y Financials

Financials (Next Earnings Date: 2017-05-28 Est.)


Revenue & Net Income
Cash & Debt
Operating Cash Flow & Free Cash Flow
Operating Cash Flow & Net Income

» Details

Guru Trades

Q1 2016

EVHC Guru Trades in Q1 2016

George Soros 41,800 sh (New)
Jim Simons 1,283,600 sh (+194.67%)
Steven Cohen 1,221,300 sh (+109.74%)
Vanguard Health Care Fund 10,993,895 sh (+21.76%)
Columbia Wanger Sold Out
Paul Tudor Jones Sold Out
Joel Greenblatt Sold Out
Andreas Halvorsen 5,122,097 sh (-34.40%)
» More
Q2 2016

EVHC Guru Trades in Q2 2016

Paul Tudor Jones 34,925 sh (New)
Andreas Halvorsen 7,817,258 sh (+52.62%)
Vanguard Health Care Fund 10,993,895 sh (unchged)
George Soros Sold Out
Jim Simons 695,500 sh (-45.82%)
Steven Cohen 55,400 sh (-95.46%)
» More
Q3 2016

EVHC Guru Trades in Q3 2016

Jeremy Grantham 2,429,000 sh (New)
Mario Gabelli 30,000 sh (New)
Vanguard Health Care Fund 10,993,895 sh (unchged)
Steven Cohen Sold Out
Paul Tudor Jones Sold Out
Andreas Halvorsen 3,419,495 sh (-56.26%)
Jim Simons 227,900 sh (-67.23%)
» More
Q4 2016

EVHC Guru Trades in Q4 2016

Paul Tudor Jones 21,316 sh (New)
Jim Simons 303,972 sh (+33.38%)
Mario Gabelli 21,717 sh (-27.61%)
Andreas Halvorsen 1,804,445 sh (-47.23%)
Vanguard Health Care Fund 4,723,860 sh (-57.03%)
Jeremy Grantham 61,024 sh (-97.49%)
» More
» Details

Insider Trades

Latest Guru Trades with EVHC

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Preferred stocks of Envision Healthcare Corp

SymbolPriceYieldDescription
EVHCPR104.645.025 1/4 % Mand Conv Pfd Shs Series -A-1-

Business Description

Industry: Health Care Providers » Medical Care    NAICS: 621111    SIC: 8011
Compare:NYSE:MD, OTCPK:SKHCF, OTCPK:CAKFY, OTCPK:MCFFY, NAS:WOOF, NAS:ACHC, NYSE:HLS, OTCPK:LTGHY, OTCPK:BDUUF, OTCPK:NWKHY, OTCPK:HHCSY, NYSE:CHE, NAS:LPNT, OTCPK:RMSYF, NAS:SCAI, NYSE:AMN, NYSE:THC, NYSE:SEM, NAS:AMED, NAS:TVTY » details
Traded in other countries:N16.Germany,
Headquarter Location:USA
Envision Healthcare Corp is a provider of healthcare services. It offers physician-led services, medical transportation services and ambulatory services.

AmSurg acquires and develops practice-based ambulatory surgery centers in partnership with physician groups. The company has a majority interest in 206 surgery centers in 33 states. AmSurg centers are typically single-specialty and perform procedures in the areas of gastroenterology, ophthalmology, and orthopedics.

Ratios

vs
industry
vs
history
Forward PE Ratio 12.97
EVHC's Forward PE Ratio is ranked higher than
87% of the 108 Companies
in the Global Medical Care industry.

( Industry Median: 18.73 vs. EVHC: 12.97 )
Ranked among companies with meaningful Forward PE Ratio only.
N/A
PB Ratio 0.95
EVHC's PB Ratio is ranked higher than
86% of the 238 Companies
in the Global Medical Care industry.

( Industry Median: 2.65 vs. EVHC: 0.95 )
Ranked among companies with meaningful PB Ratio only.
EVHC' s PB Ratio Range Over the Past 10 Years
Min: 0.93  Med: 1.63 Max: 2.61
Current: 0.95
0.93
2.61
PS Ratio 0.83
EVHC's PS Ratio is ranked higher than
68% of the 238 Companies
in the Global Medical Care industry.

( Industry Median: 1.57 vs. EVHC: 0.83 )
Ranked among companies with meaningful PS Ratio only.
EVHC' s PS Ratio Range Over the Past 10 Years
Min: 0.7  Med: 1.23 Max: 1.78
Current: 0.83
0.7
1.78
Price-to-Free-Cash-Flow 9.45
EVHC's Price-to-Free-Cash-Flow is ranked higher than
84% of the 106 Companies
in the Global Medical Care industry.

( Industry Median: 23.72 vs. EVHC: 9.45 )
Ranked among companies with meaningful Price-to-Free-Cash-Flow only.
EVHC' s Price-to-Free-Cash-Flow Range Over the Past 10 Years
Min: 1.92  Med: 4.84 Max: 17
Current: 9.45
1.92
17
Price-to-Operating-Cash-Flow 7.24
EVHC's Price-to-Operating-Cash-Flow is ranked higher than
75% of the 154 Companies
in the Global Medical Care industry.

( Industry Median: 14.15 vs. EVHC: 7.24 )
Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.
EVHC' s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 1.75  Med: 4.4 Max: 11.56
Current: 7.24
1.75
11.56
EV-to-EBIT 35.53
EVHC's EV-to-EBIT is ranked lower than
84% of the 292 Companies
in the Global Medical Care industry.

( Industry Median: 18.39 vs. EVHC: 35.53 )
Ranked among companies with meaningful EV-to-EBIT only.
EVHC' s EV-to-EBIT Range Over the Past 10 Years
Min: 3.5  Med: 7.2 Max: 27.6
Current: 35.53
3.5
27.6
EV-to-EBITDA 25.41
EVHC's EV-to-EBITDA is ranked lower than
84% of the 306 Companies
in the Global Medical Care industry.

( Industry Median: 13.46 vs. EVHC: 25.41 )
Ranked among companies with meaningful EV-to-EBITDA only.
EVHC' s EV-to-EBITDA Range Over the Past 10 Years
Min: 3.2  Med: 6.5 Max: 19.8
Current: 25.41
3.2
19.8
Shiller PE Ratio 31.11
EVHC's Shiller PE Ratio is ranked lower than
60% of the 45 Companies
in the Global Medical Care industry.

( Industry Median: 28.31 vs. EVHC: 31.11 )
Ranked among companies with meaningful Shiller PE Ratio only.
EVHC' s Shiller PE Ratio Range Over the Past 10 Years
Min: 12.58  Med: 23.28 Max: 47.91
Current: 31.11
12.58
47.91
Current Ratio 2.09
EVHC's Current Ratio is ranked higher than
76% of the 244 Companies
in the Global Medical Care industry.

( Industry Median: 1.30 vs. EVHC: 2.09 )
Ranked among companies with meaningful Current Ratio only.
EVHC' s Current Ratio Range Over the Past 10 Years
Min: 1.37  Med: 3.06 Max: 4.31
Current: 2.09
1.37
4.31
Quick Ratio 2.04
EVHC's Quick Ratio is ranked higher than
77% of the 244 Companies
in the Global Medical Care industry.

( Industry Median: 1.18 vs. EVHC: 2.04 )
Ranked among companies with meaningful Quick Ratio only.
EVHC' s Quick Ratio Range Over the Past 10 Years
Min: 1.32  Med: 2.85 Max: 4.04
Current: 2.04
1.32
4.04
Days Inventory 53.52
EVHC's Days Inventory is ranked lower than
81% of the 192 Companies
in the Global Medical Care industry.

( Industry Median: 16.88 vs. EVHC: 53.52 )
Ranked among companies with meaningful Days Inventory only.
EVHC' s Days Inventory Range Over the Past 10 Years
Min: 11  Med: 41.82 Max: 74.34
Current: 53.52
11
74.34
Days Sales Outstanding 173.32
EVHC's Days Sales Outstanding is ranked lower than
97% of the 209 Companies
in the Global Medical Care industry.

( Industry Median: 40.40 vs. EVHC: 173.32 )
Ranked among companies with meaningful Days Sales Outstanding only.
EVHC' s Days Sales Outstanding Range Over the Past 10 Years
Min: 35.64  Med: 41.22 Max: 173.32
Current: 173.32
35.64
173.32
Days Payable 182.32
EVHC's Days Payable is ranked higher than
86% of the 162 Companies
in the Global Medical Care industry.

( Industry Median: 40.41 vs. EVHC: 182.32 )
Ranked among companies with meaningful Days Payable only.
EVHC' s Days Payable Range Over the Past 10 Years
Min: 18.67  Med: 65.03 Max: 182.32
Current: 182.32
18.67
182.32

Buy Back

vs
industry
vs
history
3-Year Average Share Buyback Ratio -53.70
EVHC's 3-Year Average Share Buyback Ratio is ranked lower than
95% of the 130 Companies
in the Global Medical Care industry.

( Industry Median: -2.50 vs. EVHC: -53.70 )
Ranked among companies with meaningful 3-Year Average Share Buyback Ratio only.
EVHC' s 3-Year Average Share Buyback Ratio Range Over the Past 10 Years
Min: -53.7  Med: -1.8 Max: 1.2
Current: -53.7
-53.7
1.2

Valuation & Return

vs
industry
vs
history
Price-to-Intrinsic-Value-Projected-FCF 0.31
EVHC's Price-to-Intrinsic-Value-Projected-FCF is ranked higher than
98% of the 89 Companies
in the Global Medical Care industry.

( Industry Median: 9999.00 vs. EVHC: 0.31 )
Ranked among companies with meaningful Price-to-Intrinsic-Value-Projected-FCF only.
EVHC' s Price-to-Intrinsic-Value-Projected-FCF Range Over the Past 10 Years
Min: 0.27  Med: 0.47 Max: 1.8
Current: 0.31
0.27
1.8
Price-to-Median-PS-Value 0.68
EVHC's Price-to-Median-PS-Value is ranked higher than
81% of the 199 Companies
in the Global Medical Care industry.

( Industry Median: 1.04 vs. EVHC: 0.68 )
Ranked among companies with meaningful Price-to-Median-PS-Value only.
EVHC' s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.75  Med: 1.12 Max: 2.2
Current: 0.68
0.75
2.2
Earnings Yield (Greenblatt) % 2.81
EVHC's Earnings Yield (Greenblatt) % is ranked lower than
72% of the 334 Companies
in the Global Medical Care industry.

( Industry Median: 4.98 vs. EVHC: 2.81 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) % only.
EVHC' s Earnings Yield (Greenblatt) % Range Over the Past 10 Years
Min: 3.6  Med: 13.9 Max: 28.5
Current: 2.81
3.6
28.5
Forward Rate of Return (Yacktman) % 25.23
EVHC's Forward Rate of Return (Yacktman) % is ranked higher than
81% of the 119 Companies
in the Global Medical Care industry.

( Industry Median: 11.19 vs. EVHC: 25.23 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) % only.
EVHC' s Forward Rate of Return (Yacktman) % Range Over the Past 10 Years
Min: 17.8  Med: 26.2 Max: 58.7
Current: 25.23
17.8
58.7

More Statistics

Revenue (TTM) (Mil) $3,696
EPS (TTM) $ -0.50
Beta0.34
Short Percentage of Float8.54%
52-Week Range $53.12 - 83.27
Shares Outstanding (Mil)117.52

Analyst Estimate

Dec17 Dec18
Revenue (Mil $) 10,480 11,270
EPS ($) 4.20 4.93
EPS without NRI ($) 4.20 4.93
EPS Growth Rate
(Future 3Y To 5Y Estimate)
15.00%
Dividends per Share ($)
» More Articles for EVHC

Headlines

Articles On GuruFocus.com
Envision Healthcare Sets Earnings Release and Conference Call Dates for First-Quarter 2017 Results Apr 18 2017 
Weekly Top Insider Buys Highlight for the Week of March 17 Mar 19 2017 
Envision Healthcare Sets Earnings Release and Conference Call Dates for Fourth-Quarter and Full-Year Feb 13 2017 
Howard Marks' Largest Trades in Second Quarter Sep 29 2015 
Howard Marks Buys 13 New Stocks in Q3 Nov 14 2014 
Weekly CFO Sells Highlight: V, SCLN, VR, AMSG Jun 25 2012 
AmSurg Corp: Free Cash Flow not what it seems (AMSG) Aug 04 2011 
Amsurg Corp. (AMSG) Executive VP & CFO Claire M Gulmi sells 30,000 Shares Mar 17 2011 
Amsurg Corp. (AMSG) Executive VP & CFO Claire M Gulmi sells 27,500 Shares Nov 12 2010 
Amsurg Corp. Reports Operating Results (10-Q) Nov 05 2010 

More From Other Websites
Envision Healthcare Sets Earnings Release and Conference Call Dates for First-Quarter 2017 Results Apr 18 2017
Envision (EVHC) Teams Up with Lyft to Focus on Transportation Mar 30 2017
AMR-Lyft make patient transportation deal Mar 29 2017
American Medical Response and Lyft Announce Partnership Mar 29 2017
Should You Get Rid of Envision Healthcare (EVHC) Now? Mar 27 2017
Weekly Top Insider Buys Highlight for the Week of March 17 Mar 19 2017
Envision Healthcare to Present at Oppenheimer 27th Annual Healthcare Conference on March 21, 2017 Mar 17 2017
Envision Healthcare to Present at the Barclays Global Healthcare Conference on March 14, 2017 Mar 08 2017
[$$] Envision Healthcare to Acquire Private Equity-Backed Imaging Advantage Mar 07 2017
Envision Healthcare Enters Definitive Agreement to Acquire Imaging Advantage Mar 07 2017
ETFs with exposure to Envision Healthcare Corp. : March 6, 2017 Mar 06 2017
Envision Healthcare Corp. :EVHC-US: Earnings Analysis: 2016 By the Numbers : March 6, 2017 Mar 06 2017
The Biggest Loser: Envision Healthcare Tumbles 6.3% Mar 01 2017
Envision Healthcare to Present at the Raymond James 38th Annual Institutional Investors Conference... Mar 01 2017
Edited Transcript of EVHC.N earnings conference call or presentation 28-Feb-17 10:00pm GMT Feb 28 2017
Envision Healthcare reports 4Q loss Feb 28 2017
Envision Healthcare Reports 2016 Fourth Quarter and Full Year Financial Results Feb 28 2017
Envision Declares Quarterly Preferred Stock Dividend Feb 27 2017
Envision Healthcare Sets Earnings Release and Conference Call Dates for Fourth-Quarter and Full-Year... Feb 13 2017

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)